University of Glasgow
Overview
The University of Glasgow is a public research university that invests in its own spin-out companies to commercialize innovation and research. Its investment activities are managed through its Research & Innovation Services and IP & Commercialisation team. The university provides pre-seed and seed funding, often through grants and equity, to ventures emerging from its academic departments. A specific initiative is the Innovation Cluster Development Fund, which supports projects with commercial potential in areas like energy, health sciences, and critical technologies. The university co-invests alongside venture firms and angel investors to support its spin-outs, such as its investment in Clyde Hydrogen.
Portfolio Companies
5
Website
gla.ac.ukInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neuranics | Apr 2025 | Seed | Co-investor |
| Solasta Bio | Sep 2024 | Series A | Co-investor |
| Clyde Hydrogen | Apr 2024 | Pre Seed | Co-investor |
| Oqc Tech | Apr 2020 | Grant | Co-investor |
| Epigem Limited | Jan 2019 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.